| Drug Type Monoclonal antibody | 
| Synonyms DNP-019 | 
| Target- | 
| Action modulators | 
| Mechanism Immunomodulators | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingPreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| COVID-19 | Preclinical | South Korea  | 01 Jan 2021 | 






